X0306 4 2021-06-28 0 0001671284 Bright Health Group Inc. BHG 0001629794 New Enterprise Associates 15, L.P. 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 0001640031 NEA Partners 15, L.P. 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 0 0 1 0 Common Stock 2021-06-28 4 C 0 10601925 A 57461346 D Common Stock 2021-06-28 4 C 0 26703498 A 84164844 D Common Stock 2021-06-28 4 C 0 19549068 A 103713912 D Common Stock 2021-06-28 4 C 0 3327852 A 107041764 D Series A Preferred 2021-06-28 4 C 0 15619807 0.00 D Common Stock 10601925 0 D Series B Preferred 2021-06-28 4 C 0 8901166 0.00 D Common Stock 26703498 0 D Series C Preferred 2021-06-28 4 C 0 6516356 0.00 D Common Stock 19549068 0 D Series D Preferred Stock 2021-06-28 4 C 0 1109284 0.00 D Common Stock 3327852 0 D Each share of the Issuer's Series A Preferred Stock converted into shares of the Issuer's common stock ("Common Stock") on a 1:0.67874873 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date. The securities are directly held by New Enterprise Associates 15, L.P. ("NEA 15") and are indirectly held by NEA Partners 15, L.P. ("NEA Partners 15"), the sole general partner of NEA 15, NEA 15 GP, LLC ("NEA 15 GP"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP (collectively, the "Managers"), together, the "Indirect Reporting Persons"). The Managers of NEA 15 GP are Forest Baskett, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, Scott D. Sandell and Peter W. Sonsini. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Indirect Reporting Persons have no pecuniary interest. Each share of the Issuer's Series B Preferred Stock, Series C Preferred Stock, and Series D Preferred Stock converted into shares of Common Stock on a 1:3 basis immediately prior to the closing of the Issuer's initial public offering. These preferred shares had no expiration date. /s/ Sasha Keough, attorney-in-fact 2021-06-30